Published in Am J Physiol Renal Physiol on February 01, 2006
In vitro stimulation of HDL anti-inflammatory activity and inhibition of LDL pro-inflammatory activity in the plasma of patients with end-stage renal disease by an apoA-1 mimetic peptide. Kidney Int (2009) 2.09
Targeting the transcription factor Nrf2 to ameliorate oxidative stress and inflammation in chronic kidney disease. Kidney Int (2013) 1.93
Integrative biology identifies shared transcriptional networks in CKD. J Am Soc Nephrol (2014) 1.71
Metabolite profiling identifies markers of uremia. J Am Soc Nephrol (2010) 1.63
Serum metabolomic profiles from patients with acute kidney injury: a pilot study. J Chromatogr B Analyt Technol Biomed Life Sci (2012) 1.55
HDL metabolism and activity in chronic kidney disease. Nat Rev Nephrol (2010) 1.32
Serum amyloid A in uremic HDL promotes inflammation. J Am Soc Nephrol (2012) 1.27
Atorvastatin and low-density lipoprotein cholesterol in type 2 diabetes mellitus patients on hemodialysis. Clin J Am Soc Nephrol (2011) 1.19
Paraoxonase enzyme activity and dyslipidemia in chronic kidney disease patients. J Nephropathol (2012) 1.08
Lipoprotein abnormalities associated with mild impairment of kidney function in the multi-ethnic study of atherosclerosis. Clin J Am Soc Nephrol (2007) 1.07
Circulating FGF21 levels are progressively increased from the early to end stages of chronic kidney diseases and are associated with renal function in Chinese. PLoS One (2011) 1.05
Plasma-advanced oxidation protein products are potent high-density lipoprotein receptor antagonists in vivo. Circ Res (2009) 1.05
Exploring metabolic dysfunction in chronic kidney disease. Nutr Metab (Lond) (2012) 1.04
Adverse effects of simulated hyper- and hypo-phosphatemia on endothelial cell function and viability. PLoS One (2011) 0.99
Association of dyslipidemia with renal outcomes in chronic kidney disease. PLoS One (2013) 0.98
Retracted Oxidized LDL modulates apoptosis of regulatory T cells in patients with ESRD. J Am Soc Nephrol (2009) 0.97
HDL proteome in hemodialysis patients: a quantitative nanoflow liquid chromatography-tandem mass spectrometry approach. PLoS One (2012) 0.95
Dyslipidemia, kidney disease, and cardiovascular disease in diabetic patients. Rev Diabet Stud (2013) 0.95
Causes of dysregulation of lipid metabolism in chronic renal failure. Semin Dial (2009) 0.94
Renal dysfunction potentiates foam cell formation by repressing ABCA1. Arterioscler Thromb Vasc Biol (2009) 0.94
Effects of add-on fluvastatin therapy in patients with chronic proteinuric nephropathy on dual renin-angiotensin system blockade: the ESPLANADE trial. Clin J Am Soc Nephrol (2010) 0.94
Lower HDL-C and apolipoprotein A-I are related to higher glomerular filtration rate in subjects without kidney disease. J Lipid Res (2010) 0.92
Reverse cholesterol transport pathway in experimental chronic renal failure. Am J Nephrol (2009) 0.92
Protective Effects of Luteolin on Diabetic Nephropathy in STZ-Induced Diabetic Rats. Evid Based Complement Alternat Med (2011) 0.90
Plasma phospholipid transfer protein, cholesteryl ester transfer protein and lecithin:cholesterol acyltransferase in end-stage renal disease (ESRD). Nephrol Dial Transplant (2009) 0.89
Mild and moderate pre-dialysis chronic kidney disease is associated with increased coronary artery calcium. Vasc Health Risk Manag (2011) 0.88
Role of dyslipidemia in impairment of energy metabolism, oxidative stress, inflammation and cardiovascular disease in chronic kidney disease. Clin Exp Nephrol (2013) 0.87
Chronic kidney disease delays VLDL-apoB-100 particle catabolism: potential role of apolipoprotein C-III. J Lipid Res (2009) 0.87
Mechanisms for increased cardiovascular disease in chronic kidney dysfunction. Curr Opin Nephrol Hypertens (2009) 0.86
Clinical assessment and management of dyslipidemia in patients with chronic kidney disease. Clin Exp Nephrol (2012) 0.86
Lipoprotein lipase deficiency in chronic kidney disease is accompanied by down-regulation of endothelial GPIHBP1 expression. Clin Exp Nephrol (2011) 0.86
Cholesterol Metabolism in CKD. Am J Kidney Dis (2015) 0.84
Salutary effects of hemodialysis on low-density lipoprotein proinflammatory and high-density lipoprotein anti-inflammatory properties in patient with end-stage renal disease. J Natl Med Assoc (2011) 0.84
Genetic determinants of cardiometabolic risk: a proposed model for phenotype association and interaction. J Clin Lipidol (2012) 0.84
Effect of exercise on cardiac tissue oxidative and inflammatory mediators in chronic kidney disease. Am J Nephrol (2008) 0.83
Post-transcriptional nature of uremia-induced downregulation of hepatic apolipoprotein A-I production. Transl Res (2012) 0.83
Kidney Function as a Determinant of HDL and Triglyceride Concentrations in the Australian Population. J Clin Med (2016) 0.83
Role of lipotoxicity in endothelial dysfunction. Heart Fail Clin (2012) 0.82
Statins in the management of dyslipidemia associated with chronic kidney disease. Nat Rev Nephrol (2012) 0.82
Disorders of lipid metabolism and chronic kidney disease in the elderly. Semin Nephrol (2009) 0.82
Reasons for the lack of salutary effects of cholesterol-lowering interventions in end-stage renal disease populations. Blood Purif (2013) 0.82
HDL abnormalities in nephrotic syndrome and chronic kidney disease. Nat Rev Nephrol (2015) 0.82
Regression of albuminuria and hypertension and arrest of severe renal injury by a losartan-hydrochlorothiazide association in a model of very advanced nephropathy. PLoS One (2013) 0.82
Hyperlipidemia, oxidative stress, and intima media thickness in children with chronic kidney disease. Pediatr Nephrol (2012) 0.81
Association of cholesterol levels with mortality and cardiovascular events among patients with CKD and different amounts of proteinuria. Clin J Am Soc Nephrol (2013) 0.81
Lipid abnormalities, lipoprotein (a) and apoprotein pattern in non-dialyzed patients with chronic kidney disease. Indian J Clin Biochem (2010) 0.81
The evolving understanding of the contribution of lipid metabolism to diabetic kidney disease. Curr Diab Rep (2015) 0.81
An integrated lipidomics and metabolomics reveal nephroprotective effect and biochemical mechanism of Rheum officinale in chronic renal failure. Sci Rep (2016) 0.81
Dysregulation of hepatic fatty acid metabolism in chronic kidney disease. Nephrol Dial Transplant (2012) 0.80
Amelioration of nephropathy with apoA-1 mimetic peptide in apoE-deficient mice. Nephrol Dial Transplant (2010) 0.80
Di (2-ethylhexyl) Phthalate Exposure Impairs Growth of Antral Follicle in Mice. PLoS One (2016) 0.80
Role of Myeloperoxidase in Patients with Chronic Kidney Disease. Oxid Med Cell Longev (2016) 0.79
Very Low Density Lipoprotein Metabolism in Patients with Chronic Kidney Disease. Cardiorenal Med (2012) 0.79
Chronic kidney disease is associated with increased coronary artery atherosclerosis as revealed by multidetector computed tomographic angiography. Tex Heart Inst J (2012) 0.79
Managing cardiovascular risk in people with chronic kidney disease: a review of the evidence from randomized controlled trials. Ther Adv Chronic Dis (2011) 0.79
Plasma lipoprotein(a) levels are associated with mild renal impairment in type 2 diabetics independent of albuminuria. PLoS One (2014) 0.78
Vitamin E tocotrienol supplementation improves lipid profiles in chronic hemodialysis patients. Vasc Health Risk Manag (2013) 0.78
The Role of Statin Therapy for Primary Prevention: What is the Evidence? Curr Atheroscler Rep (2012) 0.78
Incident chronic kidney disease and newly developed complications related to renal dysfunction in an elderly population during 5 years: a community-based elderly population cohort study. PLoS One (2013) 0.78
Dysglycemia but not lipids is associated with abnormal urinary albumin excretion in diabetic kidney disease: a report from the Kidney Early Evaluation Program (KEEP). BMC Nephrol (2012) 0.78
Risk of New-Onset Dyslipidemia After Laparoscopic Adrenalectomy in Patients with Primary Aldosteronism. World J Surg (2015) 0.78
HDL Cholesterol Level Is Associated with Contrast Induced Acute Kidney Injury in Chronic Kidney Disease Patients Undergoing PCI. Sci Rep (2016) 0.77
Reduced kidney lipoprotein lipase and renal tubule triglyceride accumulation in cisplatin-mediated acute kidney injury. Am J Physiol Renal Physiol (2012) 0.77
Changes in serum inflammatory markers are associated with changes in apolipoprotein A1 but not B after the initiation of dialysis. Nephrol Dial Transplant (2013) 0.77
Lycopene ameliorates renal function in rats with streptozotocin-induced diabetes. Int J Clin Exp Pathol (2014) 0.77
Systemic and renal lipids in kidney disease development and progression. Am J Physiol Renal Physiol (2015) 0.77
The lipid story in chronic kidney disease: a long story with a happy end? Int Urol Nephrol (2013) 0.76
Effect of extended-release niacin on cardiovascular events and kidney function in chronic kidney disease: a post hoc analysis of the AIM-HIGH trial. Kidney Int (2015) 0.76
Risk factors for renal impairment revealed after unilateral adrenalectomy in patients with primary aldosteronism. Medicine (Baltimore) (2016) 0.75
Lysophosphatidylcholine, oxidized low-density lipoprotein and cardiovascular disease in Korean hemodialysis patients: analysis at 5 years of follow-up. J Korean Med Sci (2013) 0.75
Correlation between Serum Lipid Levels and Measured Glomerular Filtration Rate in Chinese Patients with Chronic Kidney Disease. PLoS One (2016) 0.75
Ezetimibe and simvastatin for the prevention of cardiovascular events in predialysis chronic kidney disease patients: a review. Int J Nephrol Renovasc Dis (2012) 0.75
Dual PPAR α / γ Agonism Normalizes Lipoprotein Profile of Renal Dyslipidemia. PPAR Res (2013) 0.75
Niacin in patients with chronic kidney disease: Is it effective and safe? Kidney Res Clin Pract (2013) 0.75
Relation of atherogenic lipoproteins with estimated glomerular filtration rate decline: a longitudinal study. BMC Nephrol (2015) 0.75
Novel missense variants in LCAT and APOB genes in an Italian kindred with familial lecithin:cholesterol acyltransferase deficiency and hypobetalipoproteinemia. J Clin Lipidol (2012) 0.75
Electronegative LDL-mediated cardiac electrical remodeling in a rat model of chronic kidney disease. Sci Rep (2017) 0.75
Nonesterified fatty acids and cardiovascular mortality in elderly men with CKD. Clin J Am Soc Nephrol (2015) 0.75
Glomerular filtration rate and proteinuria associations with coronary artery calcium among HIV-infected and HIV-uninfected men in the Multicenter AIDS Cohort Study. Coron Artery Dis (2017) 0.75
Unusual Dyslipidemia in Patients with Chronic Kidney Diseases. J Clin Diagn Res (2017) 0.75
Association between high-density lipoprotein cholesterol and renal function in elderly hypertension: a cross-sectional study in Chinese population. Medicine (Baltimore) (2015) 0.75
Impaired postprandial lipemic response in chronic kidney disease. Kidney Int (2016) 0.75
Modified Lipids and Lipoproteins in Chronic Kidney Disease: A New Class of Uremic Toxins. Toxins (Basel) (2016) 0.75
A comparative study of the effect of icodextrin based peritoneal dialysis and hemodialysis on lipid metabolism. Indian J Nephrol (2013) 0.75
PCSK9 Plasma Concentrations Are Independent of GFR and Do Not Predict Cardiovascular Events in Patients with Decreased GFR. PLoS One (2016) 0.75
Association between Low Serum Bicarbonate Concentrations and Cardiovascular Disease in Patients in the End-Stage of Renal Disease. Diseases (2016) 0.75